StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$105.88+0.28 (+0.27%)

Close on Nov 17, 2026Market cap $4.73BP/E –Yield –

Grail price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Grail's price to sales ratio was 34.0× on Nov 11, 2026, against 28.1× a year earlier. Over the last 2 years it ranged from 4.9× to 38.8×, with a median of 14.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202634.0×+12.1
2025Dec 31, 202521.8×+16.8
2024Dec 31, 20245.0×–

More Grail figures

See a number that looks wrong?